BiotechTube
Home/Advesya/Thomas Gidoin
TG

Thomas Gidoin

Chief Financial Officer

Advesya

Therapeutic Areas

OncologyAutoimmune Diseases

Advesya Pipeline

DrugIndicationPhase
ADV-101Oncology (e.g., Esophageal Cancer)Phase 1
CCTx-001Oncology (likely), Autoimmune (potential)Phase 1

Leadership Team at Advesya

KP
Ksenija Pavletic
Chief Executive Officer, Board Member
JH
Jens Hasskarl
Chief Medical Officer
ER
Erik Rutjens
Chief Technology Officer
RC
Richard C. A. Sainson
Chief Scientific Officer
DC
Dr. Christophe Ferrand
Academic Founder, Board Member
DM
Dr. Marina Deschamps
Academic Founder
View full Advesya profile